Are you ready for #ISNI2025? Join @hwiendl @QuintanaLabHMS @jonykipnis @LatorreDanielaa @AkassoglouLab @Britta_in_Bern for a program packed full of great #neuroimmunology updates. See you in beautiful Japan!#WeAreNeuroimmunology. https://t.co/ZzhfH93eNQ

Join @NASEMHealth’s #NeuroForum for a virtual workshop, 10/22-23, to explore connections between the brain & peripheral organ systems & their potential to foster a more holistic approach to #BrainHealth: https://t.co/IO4TxC5yda

The first patient in Phase 1b trial for Alzheimer's disease has been dosed with the fibrin-targeting immunotherapy. I am deeply grateful to the patients, clinical centers, the team at Therini Bio, and all the scientists in my lab making the foundational discoveries on fibrin in

Fascinating plenaries on day 2 of #AAIC25 @AkassoglouLab explaining how "fibrinogen is a bloody brake on repair and a gas pedal for neurodegeneration" & Prof Maria Grazia Spillantini showing how "tau causes a bad case of indigestion in microglia" #dementiaresearch

Such an incredible tour de force presented at Day 2 plenary #AAIC25, demonstrating pioneering efforts by @AkassoglouLab in uncovering neurovascular interactions in #Alzheimer's disease...from bench to bedside👏👏👏

#AAIC25 attendees, don’t miss this morning’s plenary session at 11 a.m. in Hall ABC, featuring 🟣 Maria Grazia Spillantini, Ph.D., Professor, Molecular Neurology in the Clinical School, at the University of Cambridge United Kingdom. 🟣 @AkassoglouLab, Professor, Department of

MSIF is proud to announce Professor Ludwig Kappos as the 2025 #CharcotAward recipient, honouring a lifetime of impact in #MSResearch. 🏆🔬 From pioneering treatments to mentoring researchers worldwide, his legacy is global. 🌎 Read more: https://t.co/M5phfjV3w9   @RC2NB

A wonderful 2 d visit in Sweden @uppsalauni to deliver the Rudbeck Lecture & serve as the “Opponent” for an outstanding Thesis Defense w/ an unexpected viewing of the original books of Carolus Linnaeus & Andreas Vesalius at the Univ Library. Grateful to my amazing host Peetra

We are hiring! JEM seeks an Executive Editor to lead our editorial team in NYC. Responsibilities include guiding journal strategy, managing an editorial team, engaging with researchers, and more. Apply here 👉 https://t.co/AnvwwgUWfq #STMjobs #PublishingJobs #ScienceJobs

It’s my honor to receive the career transition award from the Warren Alpert Foundation. I look forward to making more exciting discoveries in neurovascular dysfunction in neurologic diseases. Thank you, Katerina @AkassoglouLab for your support and outstanding mentorship!

Congrats to Zhaoqi Yan @yan_zhaoqi postdoc fellow @AkassoglouLab named 2025 Warren Alpert Distinguished Scholar for outstanding creativity in neuroscience. This $400K award will support Zhaoqi’s research on the BBB & blood proteins in neurological diseases https://t.co/mkfynNfyWW

Thanks @BIG_CenterWashU @jonykipnis @UVA Dr.Tajie Harris @GladstoneInst @AkassoglouLab @IsaacChiuLab @Harvard_Imm @ZippFrauke @uni_mainz_eng @Co_Biologists for your kind support! Look forward to the highly anticipated #NeuroimmuneGRC2025 , starting today!

Still in 2008, despite the challenging motion effects of breathing and heartbeat, @DavalosLab & @AkassoglouLab did the almost impossible task in imaging microglia acutely & chronically in the spinal cord in vivo for the 1st time: https://t.co/tc5znuUGTF.🤩 #20YearsInVivoMGImaging

Therini Bio advances neurodegeneration drug to next phase #longevity #biotech #neurodegeneration #Alzheimers https://t.co/s6nLo6l2ud

Excited to share Therini Bio's positive Phase 1a in healthy volunteers, which paves the way for advancing fibrin antibody therapies originally developed in my lab in two Phase 1b trials in patients w/ Alzheimer’s Disease and Diabetic Macular Edema. https://t.co/JxZxew5cuf

Looking forward to speaking today @ASIPath on "blood drivers of neuroinflammation: from mechanisms to clinical trials". Join us if you are attending #ASIP2025 #Pathobiology2025 today in Portland! https://t.co/YbnGYMJsHK

The 2025 Breakthrough Prize in Life Sciences goes to Alberto Ascherio, who showed the key risk factor for multiple sclerosis is infection with the Epstein-Barr virus; and to Stephen Hauser, who discovered central mechanisms of the disease and developed life-changing treatments

Congratulations to Dr. Stephen Hauser for winning the 2025 Breakthrough Prize @brkthroughprize in Life Sciences for B cell therapies that transformed the treatment landscape for Multiple Sclerosis. It has been our privilege @UCSF to learn from & be inspired by his